Kardiovaskulära implantat - Endovaskulära produkter - Del 2: Stenter (ISO 25539-2:2020)
Status:
Gällande
Köp denna standard
StandardSvensk standard
·
SS-EN ISO 25539-2:2020
Kardiovaskulära implantat - Endovaskulära produkter - Del 2: Stenter (ISO 25539-2:2020)
Prenumerera på standarder med tjänst SIS Abonnemang. Genom att prenumerera får du effektiv åtkomst till gällande standarder och säkerställer att ditt företag alltid har tillgång till senaste utgåvan.
Läs mer om SIS Abonnemang
This document specifies requirements for the evaluation of stent systems (vascular stents and delivery systems) and requirements with respect to nomenclature, design attributes and information supplied by the manufacturer, based upon current medical knowledge. Guidance for the development of in vitro test methods is included in Annex D. This document is supplemental to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.
NOTE 1 Due to the variations in the design of implants covered by this document, and in some cases due to the emergence of novel types of such implants, acceptable standardized in vitro tests and clinical results are not always available. As further scientific and clinical data become available, appropriate revision of this document will be necessary.
This document is applicable to vascular stents and vascular scaffolds (e.g. absorbable vascular scaffolds) used to treat vascular stenoses or other vascular abnormalities or pathologies. Some of the requirements are specific to endovascular treatment of arterial stenoses. Although uses of stent systems other than treatment of arterial stenoses (e.g. venous stenting) are within the scope of this document, comprehensive requirements and testing are not described for these uses. Similarly, specific stent configurations (e.g. bifurcation stents) are within the scope, but comprehensive requirements and testing are not described for these devices.
Stents used in combination with an endovascular prosthesis to complete the treatment of a lesion, including bridging stents (e.g. stents placed in the renal arteries after deployment of a fenestrated endovascular prosthesis), are within the scope of this document, but test methods are not described for the combination. ISO 25539-1 also provides information relevant to the preclinical in vivo and clinical evaluations of such stents.
Vascular stents that have surface modifications, such as drug and/or other co ...
Kardiovaskulära implantat - Endovaskulära produkter - Del 2: Stenter (ISO 25539-2:2020)
Prenumerera på standarder med tjänst SIS Abonnemang. Genom att prenumerera får du effektiv åtkomst till gällande standarder och säkerställer att ditt företag alltid har tillgång till senaste utgåvan.
Läs mer om SIS Abonnemang